Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention.
Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties.
The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas City, Missouri, USA) composed of 16,302 patients with Parkinson disease.
The second “Anticholinergic drugs and risk of dementia: case-control study” view here utilized 14,453 patients with dementia and 86,403 controls from the UK Clinical Practice Research Datalink.
Both studies observed a robust relationship between the use of drugs with anticholinergic properties and adverse consequences, including dementia, increased risks of visit to emergency departments and risk of fracture. Both studies demonstrate the importance of large electronic health record systems in understanding adverse drug events.
More RSI News
RSI contributes to newly published book on Blood Safety.
Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring…
RSI Provides Technical Advice and Review to Vietnam Partners and on-site Climate Support for Workshop
Engineers Canada is a partner with the German development agency Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ) in the execution of their Enhanced Climate Services…
Neil Comer to present at OPTrust Climate Change Symposium
The OPTrust Climate Change Symposium being held NOVEMBER 19-20, 2018 in TORONTO offers an opportunity to provide new insights into how to face climate change…
Emma Hartnett 2018 recipient of Center for Produce Safety (CPS) Research Award
CPS has recently announced 13 new research awards totaling a little over $2.6 million. The awards are for research projects directed at answering critical questions…